# Alizé Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alize-pharma

- Industry: Biotechnology
- Headquarters: France
- Website: www.alz-pharma.com
- Total disclosed funding: $75M
- Latest round: Series A (Jul 31, 2019)
- Investors on record: 8

## About

Established in 2007 and based in Ecully, France, Alizé Pharma operates as a biotechnology company that focuses on developing therapeutic peptides for the treatment of rare endocrine and metabolic diseases.

## Funding rounds

- Series A, Jul 31, 2019, $75M — OrbiMed Advisors, Novo Holdings, Pontifax Venture Capital, Kurma Partners, Credit Agricole Creation, Sham Innovation Santé, TAB Consulting, LSPvc

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Novo Holdings — Series A
- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Series A
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series A
- Credit Agricole Creation (https://capitalatlas.ai/funds/credit-agricole-creation) — Series A
- Sham Innovation Santé — Series A
- TAB Consulting — Series A
- LSPvc — Series A